rethinkPeptides Search
Menu
Research citation

Cardiovascular, Metabolic, and Safety Outcomes with Semaglutide by Baseline Age: Post Hoc Analysis of SUSTAIN 6 and PIONEER 6.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Cardiovascular, Metabolic, and Safety Outcomes with Semaglutide by Baseline Age: Post Hoc Analysis of SUSTAIN 6 and PIONEER 6.

Diabetes therapy : research, treatment and education of diabetes and related disorders, 16(1), 15-28

Citation

Bain, Stephen C; Belmar, Nicolas; Hoff, Søren T; Husain, Mansoor; Rasmussen, Søren; Vilsbøll, Tina; Petrie, Mark C. (2025). Cardiovascular, Metabolic, and Safety Outcomes with Semaglutide by Baseline Age: Post Hoc Analysis of SUSTAIN 6 and PIONEER 6.. Diabetes therapy : research, treatment and education of diabetes and related disorders, 16(1), 15-28. https://doi.org/10.1007/s13300-024-01659-7